PHARMACYTE BIOTECH, INC. Net Income (Loss) Attributable to Noncontrolling Interest
PHARMACYTE BIOTECH, INC. (PMCB) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$3.05 million for the 3-month period ending 2025-01-31, per its 10-Q filed 2025-03-17.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2025-03-17
- PHARMACYTE BIOTECH, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-01-31 was -$3.05M.
- PHARMACYTE BIOTECH, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-10-31 was -$2.96M.
- PHARMACYTE BIOTECH, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-01-31 was -$5.62M.
- PHARMACYTE BIOTECH, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2023-10-31 was -$2.26M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month |
|---|---|---|
| 2025-01-31 | -$3.05M 10-Q · filed 2025-03-17 | -$6.00M derived: sum of 2 quarters · filed 2025-03-17 |
| 2024-10-31 | -$2.96M 10-Q · filed 2024-12-13 | |
| 2024-01-31 | -$5.62M 10-Q · filed 2025-03-17 | -$7.88M derived: sum of 2 quarters · filed 2025-03-17 |
| 2023-10-31 | -$2.26M 10-Q · filed 2024-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |